Targeting the plantaris tendon during surgery to correct ankle equinus in children
Official title: The Effect of Targeting the Plantaris Muscle-tendon Unit in Surgical Correction of Ankle Equinus in Children
Run by University of Alberta · NCT07090057 · Data updated 2026-11-12
This trial tests whether cutting the small plantaris tendon, together with standard calf-lengthening surgery, helps children aged 4–17 with ankle equinus walk and use their feet better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 4 Years to 17 Years |
| Sex | All |
| Enrollment | 42 (estimated) |
| Sponsor | University of Alberta Academic / other |
| Locations | 1 site (Edmonton, Alberta) |
| Status | Recruiting |
| Started | March 13, 2023 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | March 12, 2026 |
| Trial ID | NCT07090057 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 4–17 with ankle equinus (less than 10° dorsiflexion) who are scheduled for tendoachilles lengthening or gastrocnemius recession at the Stollery Children's Hospital and who meet the study's other clinical criteria are ideal candidates.
✕Probably not a fit
Children with fixed contractures, severe progressive neuromuscular disease, inability to maintain hindfoot or midfoot neutral, or who do not meet the passive plantarflexion criteria are less likely to receive benefit from this targeted intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Children aged 4–17 with ankle equinus from conditions such as idiopathic toe walking or neuromotor disorders who are scheduled for calf-lengthening surgery at Stollery Children's Hospital will be enrolled. Participants are assigned to surgical approaches that either include a targeted plantaris tenotomy or do not, alongside standard tendoachilles lengthening or gastrocnemius recession, and outcomes are measured before and after surgery. Clinical measures include ankle range of motion, gait function, and calf muscle strength, with bilateral data collected when applicable but a single assignment per participant. The study seeks to determine whether targeting the plantaris alters recovery, strength recovery, and short- to medium-term walking outcomes.
Why it matters
Potential benefit: If successful, adding plantaris release could improve ankle motion and walking function while reducing long-term weakness, need for bracing, or repeat procedures.
How similar studies have gone: The plantaris has been noted in small surgical reports as contributing to equinus but its role is poorly studied and no large trials have yet proven that targeting it improves outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria (All of the following criteria must be met): * Ability to provided informed consent/assent in English. * Pediatric patients (4-17 years) who have consented for surgery for the management of equinus contracture \* (either TA lengthening or GN recession) at the Stollery Children's Hospital * Known underlying diagnosis of any of the following: idiopathic toe walking, cerebral palsy, hereditary spastic paraparesis, traumatic brain injury, spinal cord injury/tethering, hereditary sensory-motor neuropathy, stroke * Ability to maintain hindfoot and midfoot neutral during assessment * Passive plantarflexion on affected side greater than 20° and greater than degree of equinus contracture. * Note: may be isolated or in conjunction with other orthopaedic procedures; in bilateral ankle equinus procedures, data will be collected bilaterally, but included as a single participant (i.e., single randomization). Exclusion Criteria (Any one or more of the following): * Unable to provide informed consent/assent in English. * Previous surgery for equinus * Limb deficiency on affected side * Knee flexion contracture of greater than 5° * Surgical intervention of the lower extremities below the affected knee in the last twelve months * BoNTA injections below the affected knee within the last six months * Known or suspected arthrofibrosis.
Where it's running
-
Stollery Children's Hospital
Edmonton, Alberta, Canada Recruiting
Study contacts
- Principal investigator: Sukhdeep Dulai, MD, MHSc, FRCSC — University of Alberta
- Study coordinator: Ailar Ramadi, PhD
- Email: Ailar.Ramadi@albertahealthservices.ca
- Phone: 780-492-2398
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Spatial StimelMD for upper-limb recovery after stroke or traumatic brain injury
This trial will test whether adding the Spatial StimelMD device to standard rehabilitation helps adults with upper-limb weakness after stroke or traumatic brain injury improve arm movement.
-
Digital versus traditional ankle-foot orthoses for people with lower limb weakness
We will try if ankle-foot braces made with 3D scanning and printing work as well as traditional plaster-cast braces for people with leg weakness or stiffness from conditions like stroke or cerebral palsy.
-
Cryoneurolysis for shoulder pain and spasticity management
This study tests if a new cold treatment for shoulder pain can help people with hemiplegia feel better and move better compared to the usual botulinum injections.
-
How VR Can Make a Virtual Body Feel Real
This study tests different immersive virtual reality techniques to see which best makes a person feel the virtual body as their own, including in people with spinal cord injury or stroke.
-
Electrical stimulation-assisted exercise for people with lower limb paralysis
This study tests whether adding electrical stimulation during exercise can improve leg muscle strength and endurance for people with paralysis.
-
ZEPU-2000 robotic rehab for arm and leg weakness
This trial tests whether adding ZEPU-2000A, ZEPU-2000D, and ZEPU-2000E robotic rehabilitation to usual therapy helps adults with arm/leg movement problems from stroke, incomplete SCI, TBI, or related conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.